GO:0071140 resolution of mitotic recombination intermediates: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071140 describes the cleavage and rejoining of recombination intermediates during mitosis to produce two intact DNA molecules in which genetic material has been exchanged.
• The central intermediates are Holliday junctions (HJs), four-way DNA structures that must be processed by structure-selective nucleases or dissolvases to complete recombination.
• Key resolvase enzymes include GEN1, SLX4-SLX1, MUS81-EME1, and the BLM-TOP3A-RMI1-RMI2 dissolvasome, which act in partially redundant pathways.
• Defects in resolution cause persistent recombination intermediates, chromosome bridges, and genome instability, linking this process to cancer predisposition and chemosensitivity.
• Resolution is tightly regulated across the cell cycle, with CDK-dependent phosphorylation and SUMOylation controlling nuclease recruitment and activity.
• Experimental approaches include HJ resolution assays, CRISPR knockout models, and imaging of chromosome bridges to dissect resolvase function.
Description
Resolution of mitotic recombination intermediates (GO:0071140) is the biological process that completes homologous recombination (HR) during the mitotic cell cycle by cleaving and rejoining DNA intermediates to yield two intact duplex molecules with exchanged genetic material. This step is essential for the faithful repair of DNA double-strand breaks (DSBs) and for the restart of stalled replication forks, and it prevents the accumulation of toxic recombination intermediates that would otherwise block chromosome segregation. The process is conserved from yeast to humans and is executed by structure-selective nucleases and helicase-topoisomerase complexes that act on Holliday junctions (HJs) and related joint molecules. Researchers study GO:0071140 because its failure leads to genome instability, a hallmark of cancer and a driver of chemotherapy sensitivity. The resolvases that carry out this process, such as GEN1, SLX4-SLX1, and MUS81-EME1, are attractive targets for understanding chemoresistance and for developing precision oncology strategies. Moreover, the regulation of resolution by cell-cycle kinases and SUMOylation provides a paradigm for how post-translational modifications coordinate DNA repair with cell division. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0071140, covering its molecular mechanism, key genes, disease relevance, and experimental models. It is intended for scientists who need a concise, citable resource for grant writing, experimental design, and teaching.
resolution of mitotic recombination intermediates At A Glance
| GO ID | GO:0071140 |
|---|---|
| GO term | resolution of mitotic recombination intermediates |
| Ontology | biological_process |
| Synonym | None |
| Major function | Cleavage and rejoining of recombination intermediates to produce two intact DNA molecules with exchanged genetic material |
| Key intermediates | Holliday junctions, double Holliday junctions, and related joint molecules |
| Major enzymes | GEN1, SLX4-SLX1, MUS81-EME1, BLM-TOP3A-RMI1-RMI2 |
| Cellular context | Mitosis, particularly S/G2 phase, at sites of DNA double-strand breaks and stalled replication forks |
| Associated diseases | Cancer predisposition, genome instability syndromes, chemoresistance |
What Is GO:0071140?
GO:0071140, resolution of mitotic recombination intermediates, is defined as the cleavage and rejoining of intermediates formed during mitotic recombination to produce two intact DNA molecules in which genetic material has been exchanged. In practice, this involves the processing of Holliday junctions and other joint molecules by specialized nucleases or dissolvases, ensuring that recombination is completed without leaving persistent DNA links that could interfere with chromosome segregation.
Why Is resolution of mitotic recombination intermediates Important in Cell Biology?
Resolution of mitotic recombination intermediates is a critical final step in homologous recombination, ensuring that DNA repair is completed without leaving persistent joint molecules that can cause chromosome missegregation and genome instability. Defects in this process are directly linked to cancer development and to sensitivity to DNA-damaging chemotherapeutics, making the resolvases that execute this step important targets for both basic research and clinical translation.
• Completes homologous recombination to maintain genome stability during mitosis.
• Prevents accumulation of toxic Holliday junctions that block chromosome segregation.
• Defects cause chromosome bridges, micronuclei, and aneuploidy.
• Resolvase deficiencies sensitize cells to DNA-damaging agents like cisplatin and PARP inhibitors.
• GEN1 and SLX4 are mutated or dysregulated in various cancers.
• Resolution is regulated by CDK and SUMOylation, linking it to cell-cycle checkpoints.
• Provides a model for understanding structure-selective nucleases in DNA repair.
• Relevant to common fragile site expression and replication stress responses.
• Potential therapeutic target for cancer and for improving gene editing outcomes.
What Happens During resolution of mitotic recombination intermediates?
Formation of Holliday junctions and joint molecules
In simple terms: When DNA breaks are repaired by recombination, the broken ends invade a sister chromatid and create a four-way DNA junction called a Holliday junction.
During mitotic homologous recombination, a DNA double-strand break is resected and the resulting single-stranded DNA invades a homologous duplex, forming a displacement loop (D-loop). Further processing and second-end capture generate a double Holliday junction (dHJ) or related joint molecules that physically link the two DNA duplexes. These intermediates must be resolved to allow chromosome segregation and to complete repair. The structure and stability of these junctions are critical for subsequent resolution steps.
Processing by structure-selective nucleases
In simple terms: Specialized enzymes cut the Holliday junction at specific points to separate the linked DNA molecules.
Resolution is carried out by structure-selective nucleases that introduce symmetrical nicks on the Holliday junction. GEN1 is a canonical HJ resolvase that cleaves both strands to produce nicked duplexes that can be religated. In yeast, the nucleolytic resolution of recombination intermediates involves multiple resolvases with overlapping functions. SLX4 acts as a scaffold that coordinates SLX1 and other nucleases to process HJs and other branched structures.
Dissolution by helicase-topoisomerase complexes
In simple terms: Instead of cutting, a helicase can unwind the Holliday junction while a topoisomerase removes the resulting twists, merging the two DNA molecules without exchange of flanking markers.
An alternative to nucleolytic cleavage is dissolution, mediated by the BLM-TOP3A-RMI1-RMI2 complex in humans (Sgs1-Top3-Rmi1 in yeast). This complex migrates the double Holliday junction into a hemicatenane and then removes it by topoisomerase activity, resulting in non-crossover products. Dissolution is considered a safer route because it avoids the potentially mutagenic consequences of nuclease-mediated resolution.
Regulation by cell-cycle kinases and SUMOylation
In simple terms: The cell controls when and where resolution happens by adding chemical tags to the enzymes, ensuring it occurs at the right time in the cell cycle.
Resolution is tightly regulated to occur in S/G2 phase when a sister chromatid is available. CDK-dependent phosphorylation of SLX4 and other resolvase subunits promotes their recruitment to sites of recombination. SUMOylation of resolvase components, such as SLX4 and BLM, modulates their activity and interactions, providing an additional layer of control. This regulation ensures that resolution is coordinated with replication and repair.
Consequences of defective resolution
In simple terms: If resolution fails, the linked DNA molecules persist and cause chromosomes to break or missegregate when the cell divides.
Failure to resolve recombination intermediates leads to persistent joint molecules, ultrafine anaphase bridges, and chromosome breakage, resulting in genome instability. Cells lacking GEN1 or SLX4 accumulate unresolved HJs and exhibit hypersensitivity to DNA-damaging agents. GEN1 also promotes the expression of common fragile sites, and its loss alters replication stress responses. These defects contribute to cancer predisposition and chemoresistance.
Key Genes Involved in GO:0071140 resolution of mitotic recombination intermediates
The following genes encode the core enzymes and regulatory factors that execute and control the resolution of mitotic recombination intermediates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GEN1 | Holliday junction resolvase that cleaves HJs symmetrically | Knockout causes HJ accumulation and genome instability; target for cancer studies |
| SLX4 | Scaffold protein that coordinates SLX1 and other nucleases at HJs | Mutations linked to Fanconi anemia and cancer predisposition |
| SLX1 | Structure-selective nuclease that cleaves branched DNA | Functions with SLX4 in HJ resolution; studied in knockout models |
| MUS81 | Nuclease that processes branched DNA and HJs | Important for resolution of recombination intermediates in mitosis |
| EME1 | Essential partner of MUS81, required for its nuclease activity | Knockout affects MUS81 stability and resolution capacity |
| BLM | RecQ helicase that drives HJ dissolution with TOP3A | Defects cause Bloom syndrome; model for dissolution studies |
| TOP3A | Topoisomerase that removes hemicatenane links during dissolution | Essential for BLM-mediated dissolution; knockout is lethal in some models |
| RMI1 | Component of the BLM-TOP3A-RMI1-RMI2 dissolvasome | Required for dissolution; studied for its role in genome stability |
| RMI2 | Stabilizes the dissolvasome complex | Knockout affects BLM complex integrity |
| SGS1 | Yeast ortholog of BLM; helicase for HJ dissolution | Model for studying dissolution in Saccharomyces cerevisiae |
| SLX4 (yeast) | Yeast scaffold for resolvases | Genetic studies reveal redundant resolution pathways |
| YEN1 | Yeast HJ resolvase related to GEN1 | Used to dissect nucleolytic resolution in yeast |
| EXO1 | Exonuclease involved in resection and processing of recombination intermediates | Modulates resolution outcomes in yeast |
| SRS2 | Helicase that regulates recombination intermediate processing | Affects resolution pathway choice |
| RAD51 | Recombinase that forms D-loops and promotes strand invasion | Central to recombination; its activity influences resolution |
| RAD54 | Chromatin remodeler that stimulates Rad51-mediated recombination | Affects formation and resolution of HJs |
| CDK1 | Kinase that phosphorylates resolvase subunits to regulate timing | Controls cell-cycle-dependent resolution |
| SUMO | Post-translational modifier that regulates resolvase activity | Modulates SLX4 and BLM function during resolution |
How Is resolution of mitotic recombination intermediates Regulated?
Resolution of mitotic recombination intermediates is regulated at multiple levels to ensure it occurs in the correct cell-cycle phase and at the right genomic locations. CDK1-dependent phosphorylation of SLX4 and other resolvase components promotes their recruitment to recombination sites during S/G2. SUMOylation of SLX4, BLM, and other factors modulates protein-protein interactions and nuclease activity, providing a dynamic control mechanism. Additionally, the choice between nucleolytic resolution and dissolution is influenced by the availability of BLM-TOP3A-RMI1-RMI2 and by the structure of the recombination intermediate. This regulation prevents premature or inappropriate processing that could lead to loss of heterozygosity or chromosome rearrangements.
resolution of mitotic recombination intermediates and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GEN1 | Cancer, genome instability, chemosensitivity | Knockout cell lines (e.g., HCT116, U2OS) for HJ resolution assays |
| SLX4 | Fanconi anemia, cancer predisposition | Patient-derived fibroblasts or CRISPR knockout models |
| MUS81 | Cancer, replication stress | Knockout and point-mutation models to study nuclease activity |
| BLM | Bloom syndrome, cancer | Knockout or knock-in of patient mutations in cell lines |
| SLX1 | Cancer, genome instability | CRISPR knockout in cancer cell lines for sensitivity screens |
Cancer and genome instability
Defects in the resolution of mitotic recombination intermediates cause persistent Holliday junctions, chromosome bridges, and aneuploidy, all of which are hallmarks of cancer. Mutations or reduced expression of GEN1, SLX4, and other resolvases have been observed in various cancers, and loss of these enzymes sensitizes cells to DNA-damaging agents such as cisplatin and PARP inhibitors. GEN1 promotes common fragile site expression, and its depletion alters replication stress responses, further linking resolution to cancer biology.
Fanconi anemia and inherited cancer predisposition
SLX4 is one of the genes mutated in Fanconi anemia, a disorder characterized by bone marrow failure, developmental abnormalities, and cancer predisposition. Cells from Fanconi anemia patients with SLX4 mutations exhibit hypersensitivity to DNA crosslinking agents and accumulate unresolved recombination intermediates. This highlights the importance of resolution in maintaining genome stability and preventing disease.
Chemoresistance and therapeutic targeting
Tumors with defects in resolution pathways may become dependent on alternative resolvases, creating opportunities for synthetic lethal therapies. For example, cancer cells lacking GEN1 may rely on MUS81-EME1 for survival, and co-inhibition of these pathways could selectively kill tumor cells. Understanding the regulation of resolution is therefore critical for developing targeted treatments.
From resolution of mitotic recombination intermediates-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GEN1 loss cause HJ accumulation? | GEN1 knockout cell lines (e.g., HeLa, U2OS) |
| How does SLX4 phosphorylation regulate resolution? | Point-mutation knock-in of phospho-deficient SLX4 |
| What is the role of MUS81-EME1 in mitosis? | MUS81 or EME1 knockout cells |
| Can BLM dissolution be tracked in live cells? | Tagged knock-in of BLM with fluorescent protein |
| Does overexpression of GEN1 rescue resolution defects? | Overexpression of GEN1 in knockout background |
| Which resolvases are synthetic lethal? | CRISPR library screening in knockout backgrounds |
How to Study the resolution of mitotic recombination intermediates Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HJ resolution assay | Cleavage of synthetic Holliday junctions | Measure GEN1, SLX4-SLX1, MUS81-EME1 activity |
| Live-cell imaging | Chromosome bridges and resolvase foci | Assess resolution defects in knockout cells |
| CRISPR knockout screen | Synthetic lethal interactions | Identify genes that compensate for resolvase loss |
| HJ-seq | Genome-wide mapping of recombination intermediates | Detect unresolved junctions in yeast or human cells |
| In vitro dissolution assay | BLM-TOP3A-RMI1-RMI2 activity | Study dissolution mechanism and regulation |
| Western blot | Protein expression and phosphorylation | Check resolvase levels and CDK-dependent modification |
| Immunoprecipitation | Protein-protein interactions | Map SLX4 and BLM complexes |
| Comet assay | DNA damage and repair | Assess sensitivity to DNA-damaging agents |
Holliday junction resolution assays
In vitro resolution assays using synthetic Holliday junction substrates are the gold standard for measuring resolvase activity. These assays typically use radiolabeled or fluorescently labeled HJ DNA and analyze cleavage products by gel electrophoresis. They can be used with purified enzymes or cell extracts to assess GEN1, SLX4-SLX1, and MUS81-EME1 activities.
Cell-based imaging of recombination intermediates
Fluorescence microscopy can visualize chromosome bridges, ultrafine anaphase bridges, and foci of resolvases at sites of recombination. Live-cell imaging of tagged resolvases (e.g., GFP-GEN1) allows real-time tracking of resolution dynamics. These methods are useful for linking resolution defects to chromosome segregation errors.
Genome-wide screening and sequencing
CRISPR knockout library screens can identify genes that are synthetic lethal with resolvase deficiencies. Next-generation sequencing of recombination intermediates (e.g., HJ-seq) can map unresolved junctions across the genome. These approaches provide unbiased insights into resolution pathways and their crosstalk with other repair processes.
Biochemical reconstitution of dissolution
Dissolution of double Holliday junctions can be reconstituted in vitro using purified BLM, TOP3A, RMI1, and RMI2. This system allows mechanistic dissection of helicase and topoisomerase activities and their regulation by SUMOylation. It is a powerful tool for testing the effects of mutations on dissolution efficiency.
How CRISPR Can Be Used to Study GO:0071140 resolution of mitotic recombination intermediates
Knockout
CRISPR knockout of GEN1, SLX4, MUS81, or BLM is widely used to study resolution defects. Knockout cells accumulate Holliday junctions, exhibit chromosome bridges, and show hypersensitivity to DNA-damaging agents. These models are essential for dissecting the contribution of individual resolvases to genome stability.
Point Mutation
Point mutations can be introduced into resolvase catalytic domains or regulatory phosphorylation sites to separate enzymatic activity from regulation. For example, phospho-deficient SLX4 mutants can test the role of CDK phosphorylation in resolution. Such models provide mechanistic insights that knockout alone cannot.
Knock-in
Knock-in of tagged resolvases (e.g., GFP-GEN1, FLAG-SLX4) enables live-cell imaging and biochemical purification. Knock-in of patient-derived mutations (e.g., SLX4 Fanconi anemia alleles) can model disease phenotypes in isogenic cell lines. These approaches are valuable for studying resolution dynamics and disease mechanisms.
Overexpression
Overexpression of GEN1 or other resolvases can rescue resolution defects in knockout backgrounds and test for gain-of-function effects. It is also used to produce recombinant protein for in vitro assays. Overexpression models help establish causality and sufficiency of specific enzymes in resolution.
How EDITGENE Supports resolution of mitotic recombination intermediates Research
Researchers studying resolution of mitotic recombination intermediates-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. CRISPR-based models provide the gold standard for establishing causality, and EDITGENE offers a comprehensive suite of services to generate and characterize such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for resolution of mitotic recombination intermediates research.
Frequently Asked Questions About resolution of mitotic recombination intermediates
What is resolution of mitotic recombination intermediates?
It is the biological process (GO:0071140) that cleaves and rejoins DNA intermediates formed during mitotic recombination to produce two intact molecules with exchanged genetic material.
What genes are involved in resolution of mitotic recombination intermediates?
Key genes include GEN1, SLX4, SLX1, MUS81, EME1, BLM, TOP3A, RMI1, and RMI2.
What are Holliday junctions?
Holliday junctions are four-way DNA structures that form during homologous recombination and must be resolved to complete repair.
How is resolution of mitotic recombination intermediates regulated?
It is regulated by CDK-dependent phosphorylation and SUMOylation of resolvase components, ensuring cell-cycle timing.
What happens if resolution fails?
Failure leads to persistent recombination intermediates, chromosome bridges, and genome instability, which can cause cancer.
Which diseases are linked to defective resolution?
Cancer, Fanconi anemia, and Bloom syndrome are associated with defects in resolution factors.
What methods are used to study resolution of mitotic recombination intermediates?
Common methods include HJ resolution assays, live-cell imaging, CRISPR screens, and in vitro dissolution assays.
What is the role of GEN1 in resolution?
GEN1 is a Holliday junction resolvase that cleaves HJs symmetrically to complete recombination.
How does BLM contribute to resolution?
BLM, with TOP3A and RMI proteins, dissolves double Holliday junctions without crossover.
Can CRISPR be used to study resolution of mitotic recombination intermediates?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect resolvase function.
Conclusion
Resolution of mitotic recombination intermediates (GO:0071140) is a fundamental process that safeguards genome stability by ensuring the completion of homologous recombination. The coordinated action of nucleases like GEN1 and SLX4-SLX1, and the BLM-TOP3A-RMI1-RMI2 dissolvasome, is essential to prevent chromosome missegregation and cancer. Understanding its regulation and disease links offers opportunities for therapeutic intervention. EDITGENE provides end-to-end CRISPR solutions, from knockout and point-mutation models to library screening and bioinformatics, to help researchers uncover the mechanisms and vulnerabilities of this critical pathway.
References
- 1. Talhaoui I et al.. 2016. The nucleolytic resolution of recombination intermediates in yeast mitotic cells.. FEMS Yeast Res 16(6) PMID: 27509904
- 2. West SC et al.. 2015. Resolution of Recombination Intermediates: Mechanisms and Regulation.. Cold Spring Harb Symp Quant Biol 80:103-9 PMID: 26370409
- 3. Shah Punatar R et al.. 2017. Resolution of single and double Holliday junction recombination intermediates by GEN1.. Proc Natl Acad Sci U S A 114(3):443-450 PMID: 28049850
- 4. Shah Punatar R et al.. 2018. Preparation and Resolution of Holliday Junction DNA Recombination Intermediates.. Methods Enzymol 600:569-590 PMID: 29458775
- 5. Wyatt HD et al.. 2014. Holliday junction resolvases.. Cold Spring Harb Perspect Biol 6(9):a023192 PMID: 25183833
- 6. West SC et al.. 2017. Genome Instability as a Consequence of Defects in the Resolution of Recombination Intermediates.. Cold Spring Harb Symp Quant Biol 82:207-212 PMID: 29348327
- 7. Matos J et al.. 2011. Regulatory control of the resolution of DNA recombination intermediates during meiosis and mitosis.. Cell 147(1):158-72 PMID: 21962513
- 8. Benitez A et al.. 2023. GEN1 promotes common fragile site expression.. Cell Rep 42(2):112062 PMID: 36729836
